CHRSCoherus Oncology
−11.9% today · −52.1% over a year
No score: too little data.
No dividend.
Coherus Oncology (CHRS) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €103.1M. Over the past 12 months the price changed by −52.1%, with an annualised volatility of 86% and a largest fall of 70%. Hard red flags in our rules-based screen: Heavy dilution.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Red flags and notes
- Serious warning. Share count growing more than 10 % a year over three years. More in the glossary → Share count growing more than 10 % a year over three years.
- Caution. Net debt above 4× EBITDA or interest cover below 2×. More in the glossary → Net debt above 4× EBITDA or interest cover below 2×.
- Below $1 Price below one US dollar: not ranked against peers.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/B
- 1.9
- P/S
- 2.3
- Market cap (EUR)
- €103.1M
Profitability and debt
- Return on equity
- −146.3%
- Gross margin
- 68.9%
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- −11.9%
- 1 month
- −33.1%
- 1 year
- −52.1%
- Volatility, 1 yr
- 85.5%
- Max drawdown, 1 yr
- −70.2%
- Beta
- 1.14
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| HCATHealth Catalyst | 1/10 | 0.0% | −50.8% |
|---|---|---|---|
| ZNTLZentalis Pharmaceuticals | —/10 | 0.0% | 27.6% |
| AVXLAnavex Life Sciences Corp. | —/10 | 0.0% | −84.8% |
| BDTXBlack Diamond Therapeutics Inc | —/10 | 0.0% | −57.1% |
| LENZLENZ Therapeutics, Inc. | 1/10 | 0.0% | −86.0% |
| FRNMFreenome Inc. | —/10 | 0.0% | −2.4% |
| VXRTVaxart Inc | —/10 | 0.0% | 12.1% |
| ALXOALX Oncology Holdings Inc | 1/10 | 0.0% | −8.7% |
News and filings
- Coherus Oncology, Inc.: 8-K — Regulation FD disclosure; other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Oct 2026
- Coherus Oncology, Inc.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 28 Aug 2026
- Coherus Oncology, Inc.: 8-K — Regulation FD disclosure; other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 17 Aug 2026
- Coherus Oncology, Inc.: 8-K — Material agreement; agreement terminated; new financial obligation
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 17 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 4 entries
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| Rating change | —/10 | — · — | removed: Accounting red flag | Available with Invest Pro | |
| Rating change | —/10 | — · — | Serious warning. Beneish M-score above −1.78 together with very high accruals: earnings may be overstated. More in the glossary → | Available with Invest Pro | |
| Rating change | —/10 | — · — | removed: Accounting red flag | Available with Invest Pro | |
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.